Description
Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor, classified under nonsteroidal anti-inflammatory drugs (NSAIDs). It is used in preclinical and pharmacodynamic research to model inflammation, osteoarthritis, rheumatoid arthritis, and acute pain. Etoricoxib exhibits a targeted action by sparing COX-1 and selectively inhibiting COX-2, making it ideal for comparative studies with other NSAIDs.
This 60?mg strength is suitable for dose-response assays and chronic administration research.
Etoricoxib Tablets Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Etoricoxib Tablets (Hainitan / ???) |
| Active Ingredient | Etoricoxib |
| CAS Number | 202409-33-4 |
| Molecular Formula | C??H??ClN?O?S |
| Molecular Weight | 358.84 g/mol |
| Strength | 60?mg per tablet |
| Formulation | Oral tablet |
| Dosage Form | Film-coated tablet |
| Quantity per Box | 6 tablets |
| Approval Number | ????H20213565 |
| Product Code | 86910323000086 |
| Manufacturer | Shandong Langnuo Pharmaceutical Co., Ltd. |
| Barcode | 6907031122494 |
| Storage Conditions | Store below 25?°C, protect from moisture and light |
| Intended Use | Laboratory research only |
Etoricoxib Tablets Mechanism of Action
Etoricoxib selectively inhibits COX-2 enzymes, which are responsible for the synthesis of prostaglandins involved in inflammation, swelling, and pain. It does not significantly affect COX-1, preserving gastrointestinal protection and platelet function. This mechanism is suitable for studying:
Anti-inflammatory mechanisms
Pain signaling pathways
NSAID-induced side effects
Arthritis progression in animal models
Etoricoxib Tablets Research Applications
Rheumatoid arthritis and osteoarthritis models
Acute and chronic inflammation studies
Pain modulation and analgesic testing
Comparative research with non-selective NSAIDs
COX-2 inhibitor pharmacokinetics
Etoricoxib Tablets Side Effects (Observed in Lab Settings)
Gastrointestinal discomfort (low incidence vs traditional NSAIDs)
Elevated liver enzymes in long-term studies
Cardiovascular effects at high doses
Renal function fluctuations
Headache or dizziness in animal subjects
Safety & Handling
Use appropriate lab PPE (gloves, goggles, lab coat)
Avoid inhalation and contact with eyes or skin
Handle in a well-ventilated lab setting
Not for use in humans or animals
Dispose of according to institutional safety regulations
Core Keywords
Etoricoxib tablets, CAS 202409-33-4, COX-2 inhibitor, Hainitan etoricoxib, NSAID for lab research, anti-inflammatory model drug, etoricoxib 60mg research, osteoarthritis inflammation research, lab-grade etoricoxib, etoricoxib for pain models
Research Use Disclaimer
This product is intended strictly for laboratory research. It is not approved for therapeutic, diagnostic, or veterinary use. Handle only in certified facilities by trained research professionals.


Reviews
There are no reviews yet.